nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextroamphetamine—CYP2D6—Lomustine—brain cancer	0.217	0.569	CbGbCtD
Dextroamphetamine—CYP2D6—Hydroxyurea—brain cancer	0.165	0.431	CbGbCtD
Dextroamphetamine—SLC18A2—telencephalic ventricle—brain cancer	0.0226	0.107	CbGeAlD
Dextroamphetamine—SLC6A3—telencephalic ventricle—brain cancer	0.0171	0.0808	CbGeAlD
Dextroamphetamine—SLC18A2—ganglion—brain cancer	0.014	0.0665	CbGeAlD
Dextroamphetamine—SLC18A2—Dopaminergic Neurogenesis—OTX2—brain cancer	0.0122	0.108	CbGpPWpGaD
Dextroamphetamine—SLC6A3—ganglion—brain cancer	0.0106	0.0503	CbGeAlD
Dextroamphetamine—TAAR1—central nervous system—brain cancer	0.00906	0.0429	CbGeAlD
Dextroamphetamine—SLC6A2—ganglion—brain cancer	0.00857	0.0406	CbGeAlD
Dextroamphetamine—SLC6A3—hindbrain—brain cancer	0.00806	0.0381	CbGeAlD
Dextroamphetamine—SLC6A3—Dopaminergic Neurogenesis—OTX2—brain cancer	0.00726	0.0645	CbGpPWpGaD
Dextroamphetamine—Digestion impaired—Hydroxyurea—brain cancer	0.00706	0.0251	CcSEcCtD
Dextroamphetamine—SLC18A2—brainstem—brain cancer	0.0061	0.0289	CbGeAlD
Dextroamphetamine—ADRA1A—hindbrain—brain cancer	0.00604	0.0286	CbGeAlD
Dextroamphetamine—SLC18A2—Synaptic Vesicle Pathway—SYP—brain cancer	0.00604	0.0536	CbGpPWpGaD
Dextroamphetamine—Tooth disorder—Temozolomide—brain cancer	0.00569	0.0202	CcSEcCtD
Dextroamphetamine—Digestion impaired—Temozolomide—brain cancer	0.00552	0.0196	CcSEcCtD
Dextroamphetamine—SLC18A2—telencephalon—brain cancer	0.00542	0.0257	CbGeAlD
Dextroamphetamine—SLC18A2—Dopaminergic Neurogenesis—GLI2—brain cancer	0.0053	0.0471	CbGpPWpGaD
Dextroamphetamine—Pseudoephedrine—IL2—brain cancer	0.00504	0.37	CrCbGaD
Dextroamphetamine—SLC18A2—Dopaminergic Neurogenesis—GLI1—brain cancer	0.00499	0.0443	CbGpPWpGaD
Dextroamphetamine—SLC6A3—brainstem—brain cancer	0.00462	0.0219	CbGeAlD
Dextroamphetamine—Speech disorder—Carmustine—brain cancer	0.00444	0.0158	CcSEcCtD
Dextroamphetamine—Accidental injury—Carmustine—brain cancer	0.00431	0.0154	CcSEcCtD
Dextroamphetamine—Speech disorder—Temozolomide—brain cancer	0.00429	0.0153	CcSEcCtD
Dextroamphetamine—SLC18A2—medulla oblongata—brain cancer	0.00426	0.0202	CbGeAlD
Dextroamphetamine—SLC6A3—telencephalon—brain cancer	0.0041	0.0194	CbGeAlD
Dextroamphetamine—Viral infection—Temozolomide—brain cancer	0.00408	0.0145	CcSEcCtD
Dextroamphetamine—Toxic epidermal necrolysis—Procarbazine—brain cancer	0.00399	0.0142	CcSEcCtD
Dextroamphetamine—Infection—Carboplatin—brain cancer	0.00389	0.0139	CcSEcCtD
Dextroamphetamine—SLC18A2—midbrain—brain cancer	0.00389	0.0184	CbGeAlD
Dextroamphetamine—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.00389	0.0345	CbGpPWpGaD
Dextroamphetamine—SLC6A2—brainstem—brain cancer	0.00373	0.0176	CbGeAlD
Dextroamphetamine—SLC18A2—Dopaminergic Neurogenesis—SHH—brain cancer	0.0036	0.032	CbGpPWpGaD
Dextroamphetamine—CYP2D6—hindbrain—brain cancer	0.00356	0.0168	CbGeAlD
Dextroamphetamine—Photosensitivity reaction—Procarbazine—brain cancer	0.00349	0.0124	CcSEcCtD
Dextroamphetamine—ADRA1A—brainstem—brain cancer	0.00346	0.0164	CbGeAlD
Dextroamphetamine—SLC18A2—endocrine gland—brain cancer	0.00342	0.0162	CbGeAlD
Dextroamphetamine—ADRA1B—head—brain cancer	0.00341	0.0161	CbGeAlD
Dextroamphetamine—Infection—Lomustine—brain cancer	0.00341	0.0121	CcSEcCtD
Dextroamphetamine—SLC18A2—head—brain cancer	0.00337	0.016	CbGeAlD
Dextroamphetamine—SLC6A2—telencephalon—brain cancer	0.00331	0.0157	CbGeAlD
Dextroamphetamine—Sweating—Procarbazine—brain cancer	0.00327	0.0116	CcSEcCtD
Dextroamphetamine—Anorexia—Lomustine—brain cancer	0.00327	0.0116	CcSEcCtD
Dextroamphetamine—SLC6A3—Dopaminergic Neurogenesis—GLI2—brain cancer	0.00316	0.0281	CbGpPWpGaD
Dextroamphetamine—ADRA1B—central nervous system—brain cancer	0.00311	0.0147	CbGeAlD
Dextroamphetamine—Body temperature increased—Carboplatin—brain cancer	0.0031	0.011	CcSEcCtD
Dextroamphetamine—SLC18A2—central nervous system—brain cancer	0.00308	0.0146	CbGeAlD
Dextroamphetamine—ADRA1A—telencephalon—brain cancer	0.00307	0.0146	CbGeAlD
Dextroamphetamine—Injury—Carmustine—brain cancer	0.00301	0.0107	CcSEcCtD
Dextroamphetamine—SLC18A2—cerebellum—brain cancer	0.00301	0.0143	CbGeAlD
Dextroamphetamine—Decreased appetite—Lomustine—brain cancer	0.00298	0.0106	CcSEcCtD
Dextroamphetamine—SLC6A3—Dopaminergic Neurogenesis—GLI1—brain cancer	0.00297	0.0264	CbGpPWpGaD
Dextroamphetamine—SLC6A3—midbrain—brain cancer	0.00294	0.0139	CbGeAlD
Dextroamphetamine—SLC6A3—spinal cord—brain cancer	0.00287	0.0136	CbGeAlD
Dextroamphetamine—SLC6A2—gonad—brain cancer	0.00276	0.0131	CbGeAlD
Dextroamphetamine—Body temperature increased—Lomustine—brain cancer	0.00271	0.00965	CcSEcCtD
Dextroamphetamine—Affect lability—Temozolomide—brain cancer	0.00264	0.00938	CcSEcCtD
Dextroamphetamine—Tension—Procarbazine—brain cancer	0.00262	0.00932	CcSEcCtD
Dextroamphetamine—SLC6A2—medulla oblongata—brain cancer	0.0026	0.0123	CbGeAlD
Dextroamphetamine—Tranylcypromine—CYP2C9—brain cancer	0.00259	0.19	CrCbGaD
Dextroamphetamine—Nervousness—Procarbazine—brain cancer	0.00259	0.00922	CcSEcCtD
Dextroamphetamine—SLC6A3—head—brain cancer	0.00255	0.0121	CbGeAlD
Dextroamphetamine—Mood swings—Temozolomide—brain cancer	0.00254	0.00903	CcSEcCtD
Dextroamphetamine—Tremor—Procarbazine—brain cancer	0.0025	0.0089	CcSEcCtD
Dextroamphetamine—ADRA1B—brain—brain cancer	0.00247	0.0117	CbGeAlD
Dextroamphetamine—SLC18A2—brain—brain cancer	0.00244	0.0116	CbGeAlD
Dextroamphetamine—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.00241	0.00858	CcSEcCtD
Dextroamphetamine—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.00241	0.0214	CbGpPWpGaD
Dextroamphetamine—SLC6A3—central nervous system—brain cancer	0.00233	0.011	CbGeAlD
Dextroamphetamine—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.00232	0.0206	CbGpPWpGaD
Dextroamphetamine—Convulsion—Procarbazine—brain cancer	0.00231	0.00823	CcSEcCtD
Dextroamphetamine—Hypertension—Procarbazine—brain cancer	0.0023	0.0082	CcSEcCtD
Dextroamphetamine—SLC6A3—cerebellum—brain cancer	0.00228	0.0108	CbGeAlD
Dextroamphetamine—Anxiety—Procarbazine—brain cancer	0.00226	0.00806	CcSEcCtD
Dextroamphetamine—Dry mouth—Procarbazine—brain cancer	0.00222	0.00791	CcSEcCtD
Dextroamphetamine—Vomiting—Lomustine—brain cancer	0.00218	0.00776	CcSEcCtD
Dextroamphetamine—Phentermine—CYP2C9—brain cancer	0.00217	0.16	CrCbGaD
Dextroamphetamine—Infection—Procarbazine—brain cancer	0.00216	0.0077	CcSEcCtD
Dextroamphetamine—SLC6A3—Dopaminergic Neurogenesis—SHH—brain cancer	0.00215	0.0191	CbGpPWpGaD
Dextroamphetamine—Erectile dysfunction—Temozolomide—brain cancer	0.00213	0.00759	CcSEcCtD
Dextroamphetamine—Depression—Carmustine—brain cancer	0.00213	0.00758	CcSEcCtD
Dextroamphetamine—Tachycardia—Procarbazine—brain cancer	0.00212	0.00756	CcSEcCtD
Dextroamphetamine—Photosensitivity reaction—Temozolomide—brain cancer	0.00211	0.00752	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Procarbazine—brain cancer	0.0021	0.00749	CcSEcCtD
Dextroamphetamine—Weight decreased—Temozolomide—brain cancer	0.00209	0.00745	CcSEcCtD
Dextroamphetamine—SLC6A2—endocrine gland—brain cancer	0.00209	0.00987	CbGeAlD
Dextroamphetamine—Urinary tract infection—Carmustine—brain cancer	0.00208	0.00739	CcSEcCtD
Dextroamphetamine—Anorexia—Procarbazine—brain cancer	0.00207	0.00739	CcSEcCtD
Dextroamphetamine—SLC6A2—head—brain cancer	0.00206	0.00975	CbGeAlD
Dextroamphetamine—Depression—Temozolomide—brain cancer	0.00206	0.00733	CcSEcCtD
Dextroamphetamine—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.00205	0.00728	CcSEcCtD
Dextroamphetamine—CYP2D6—brainstem—brain cancer	0.00204	0.00966	CbGeAlD
Dextroamphetamine—Nausea—Lomustine—brain cancer	0.00204	0.00725	CcSEcCtD
Dextroamphetamine—Selegiline—CYP2C9—brain cancer	0.00201	0.148	CrCbGaD
Dextroamphetamine—Urinary tract infection—Temozolomide—brain cancer	0.00201	0.00714	CcSEcCtD
Dextroamphetamine—Insomnia—Procarbazine—brain cancer	0.00197	0.00701	CcSEcCtD
Dextroamphetamine—ADRA1A—endocrine gland—brain cancer	0.00194	0.00918	CbGeAlD
Dextroamphetamine—Somnolence—Procarbazine—brain cancer	0.00193	0.00689	CcSEcCtD
Dextroamphetamine—Toxic epidermal necrolysis—Etoposide—brain cancer	0.00193	0.00687	CcSEcCtD
Dextroamphetamine—ADRA1A—head—brain cancer	0.00191	0.00906	CbGeAlD
Dextroamphetamine—Decreased appetite—Procarbazine—brain cancer	0.00189	0.00674	CcSEcCtD
Dextroamphetamine—SLC6A2—central nervous system—brain cancer	0.00188	0.0089	CbGeAlD
Dextroamphetamine—Fatigue—Procarbazine—brain cancer	0.00188	0.00668	CcSEcCtD
Dextroamphetamine—Constipation—Procarbazine—brain cancer	0.00186	0.00663	CcSEcCtD
Dextroamphetamine—SLC6A3—brain—brain cancer	0.00185	0.00876	CbGeAlD
Dextroamphetamine—CYP2D6—telencephalon—brain cancer	0.00181	0.00857	CbGeAlD
Dextroamphetamine—Nateglinide—CYP2C9—brain cancer	0.0018	0.132	CrCbGaD
Dextroamphetamine—Convulsion—Hydroxyurea—brain cancer	0.00179	0.00637	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Procarbazine—brain cancer	0.00178	0.00634	CcSEcCtD
Dextroamphetamine—ADRA1B—AMPK Signaling—STRADA—brain cancer	0.00175	0.0156	CbGpPWpGaD
Dextroamphetamine—Erythema multiforme—Temozolomide—brain cancer	0.00175	0.00624	CcSEcCtD
Dextroamphetamine—ADRA1A—central nervous system—brain cancer	0.00175	0.00827	CbGeAlD
Dextroamphetamine—Urticaria—Procarbazine—brain cancer	0.00173	0.00616	CcSEcCtD
Dextroamphetamine—Abdominal pain—Procarbazine—brain cancer	0.00172	0.00613	CcSEcCtD
Dextroamphetamine—Body temperature increased—Procarbazine—brain cancer	0.00172	0.00613	CcSEcCtD
Dextroamphetamine—ADRA1A—cerebellum—brain cancer	0.00171	0.00808	CbGeAlD
Dextroamphetamine—TAAR1—GPCR ligand binding—PTCH2—brain cancer	0.00168	0.0149	CbGpPWpGaD
Dextroamphetamine—Infection—Hydroxyurea—brain cancer	0.00167	0.00596	CcSEcCtD
Dextroamphetamine—Stevens-Johnson syndrome—Etoposide—brain cancer	0.00164	0.00583	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Etoposide—brain cancer	0.00163	0.0058	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Etoposide—brain cancer	0.00162	0.00576	CcSEcCtD
Dextroamphetamine—Anorexia—Hydroxyurea—brain cancer	0.00161	0.00572	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Procarbazine—brain cancer	0.0016	0.00571	CcSEcCtD
Dextroamphetamine—Tremor—Carmustine—brain cancer	0.00156	0.00557	CcSEcCtD
Dextroamphetamine—Asthenia—Procarbazine—brain cancer	0.00156	0.00556	CcSEcCtD
Dextroamphetamine—ADRA1A—AMPK Signaling—STRADA—brain cancer	0.00156	0.0138	CbGpPWpGaD
Dextroamphetamine—Agitation—Carmustine—brain cancer	0.00153	0.00546	CcSEcCtD
Dextroamphetamine—Tremor—Temozolomide—brain cancer	0.00151	0.00538	CcSEcCtD
Dextroamphetamine—Dyspnoea—Hydroxyurea—brain cancer	0.0015	0.00535	CcSEcCtD
Dextroamphetamine—Somnolence—Hydroxyurea—brain cancer	0.0015	0.00533	CcSEcCtD
Dextroamphetamine—SLC6A2—brain—brain cancer	0.00149	0.00706	CbGeAlD
Dextroamphetamine—Diarrhoea—Procarbazine—brain cancer	0.00149	0.0053	CcSEcCtD
Dextroamphetamine—Dyspepsia—Hydroxyurea—brain cancer	0.00148	0.00528	CcSEcCtD
Dextroamphetamine—Agitation—Temozolomide—brain cancer	0.00148	0.00528	CcSEcCtD
Dextroamphetamine—Angioedema—Temozolomide—brain cancer	0.00147	0.00525	CcSEcCtD
Dextroamphetamine—TAAR1—GPCR downstream signaling—OR4C12—brain cancer	0.00147	0.0131	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—OR14C36—brain cancer	0.00147	0.0131	CbGpPWpGaD
Dextroamphetamine—Decreased appetite—Hydroxyurea—brain cancer	0.00146	0.00521	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00145	0.00518	CcSEcCtD
Dextroamphetamine—Fatigue—Hydroxyurea—brain cancer	0.00145	0.00517	CcSEcCtD
Dextroamphetamine—Convulsion—Carmustine—brain cancer	0.00145	0.00515	CcSEcCtD
Dextroamphetamine—Hypertension—Carmustine—brain cancer	0.00144	0.00513	CcSEcCtD
Dextroamphetamine—Constipation—Hydroxyurea—brain cancer	0.00144	0.00513	CcSEcCtD
Dextroamphetamine—Dizziness—Procarbazine—brain cancer	0.00144	0.00512	CcSEcCtD
Dextroamphetamine—Palpitations—Temozolomide—brain cancer	0.00142	0.00507	CcSEcCtD
Dextroamphetamine—Chest pain—Carmustine—brain cancer	0.00142	0.00506	CcSEcCtD
Dextroamphetamine—Anxiety—Carmustine—brain cancer	0.00142	0.00504	CcSEcCtD
Dextroamphetamine—Erythema multiforme—Etoposide—brain cancer	0.0014	0.00499	CcSEcCtD
Dextroamphetamine—Convulsion—Temozolomide—brain cancer	0.0014	0.00497	CcSEcCtD
Dextroamphetamine—Hypertension—Temozolomide—brain cancer	0.00139	0.00496	CcSEcCtD
Dextroamphetamine—ADRA1A—brain—brain cancer	0.00139	0.00657	CbGeAlD
Dextroamphetamine—Vomiting—Procarbazine—brain cancer	0.00138	0.00493	CcSEcCtD
Dextroamphetamine—Rash—Procarbazine—brain cancer	0.00137	0.00489	CcSEcCtD
Dextroamphetamine—Dermatitis—Procarbazine—brain cancer	0.00137	0.00488	CcSEcCtD
Dextroamphetamine—ADRA1B—G alpha (12/13) signalling events—ABR—brain cancer	0.00137	0.0122	CbGpPWpGaD
Dextroamphetamine—Anxiety—Temozolomide—brain cancer	0.00137	0.00487	CcSEcCtD
Dextroamphetamine—Headache—Procarbazine—brain cancer	0.00136	0.00486	CcSEcCtD
Dextroamphetamine—Infection—Carmustine—brain cancer	0.00135	0.00482	CcSEcCtD
Dextroamphetamine—Dry mouth—Temozolomide—brain cancer	0.00134	0.00478	CcSEcCtD
Dextroamphetamine—TAAR1—Signaling by GPCR—OR14C36—brain cancer	0.00133	0.0119	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—OR4C12—brain cancer	0.00133	0.0119	CbGpPWpGaD
Dextroamphetamine—Body temperature increased—Hydroxyurea—brain cancer	0.00133	0.00474	CcSEcCtD
Dextroamphetamine—Tachycardia—Carmustine—brain cancer	0.00133	0.00473	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Temozolomide—brain cancer	0.00132	0.00469	CcSEcCtD
Dextroamphetamine—Infection—Temozolomide—brain cancer	0.00131	0.00466	CcSEcCtD
Dextroamphetamine—Anorexia—Carmustine—brain cancer	0.0013	0.00462	CcSEcCtD
Dextroamphetamine—Nausea—Procarbazine—brain cancer	0.00129	0.0046	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Temozolomide—brain cancer	0.00127	0.00453	CcSEcCtD
Dextroamphetamine—Anorexia—Temozolomide—brain cancer	0.00125	0.00447	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Hydroxyurea—brain cancer	0.00124	0.00442	CcSEcCtD
Dextroamphetamine—Insomnia—Carmustine—brain cancer	0.00123	0.00439	CcSEcCtD
Dextroamphetamine—ADRA1A—G alpha (12/13) signalling events—ABR—brain cancer	0.00122	0.0108	CbGpPWpGaD
Dextroamphetamine—Dyspnoea—Carmustine—brain cancer	0.00121	0.00432	CcSEcCtD
Dextroamphetamine—Somnolence—Carmustine—brain cancer	0.00121	0.00431	CcSEcCtD
Dextroamphetamine—Asthenia—Hydroxyurea—brain cancer	0.00121	0.0043	CcSEcCtD
Dextroamphetamine—Insomnia—Temozolomide—brain cancer	0.00119	0.00424	CcSEcCtD
Dextroamphetamine—Decreased appetite—Carmustine—brain cancer	0.00118	0.00421	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Carmustine—brain cancer	0.00118	0.00419	CcSEcCtD
Dextroamphetamine—Dyspnoea—Temozolomide—brain cancer	0.00117	0.00418	CcSEcCtD
Dextroamphetamine—Somnolence—Temozolomide—brain cancer	0.00117	0.00417	CcSEcCtD
Dextroamphetamine—Constipation—Carmustine—brain cancer	0.00116	0.00415	CcSEcCtD
Dextroamphetamine—Dyspepsia—Temozolomide—brain cancer	0.00116	0.00412	CcSEcCtD
Dextroamphetamine—Diarrhoea—Hydroxyurea—brain cancer	0.00115	0.0041	CcSEcCtD
Dextroamphetamine—Decreased appetite—Temozolomide—brain cancer	0.00114	0.00407	CcSEcCtD
Dextroamphetamine—CYP2D6—endocrine gland—brain cancer	0.00114	0.00541	CbGeAlD
Dextroamphetamine—Gastrointestinal disorder—Temozolomide—brain cancer	0.00114	0.00405	CcSEcCtD
Dextroamphetamine—Fatigue—Temozolomide—brain cancer	0.00113	0.00404	CcSEcCtD
Dextroamphetamine—SLC6A3—Parkinsons Disease Pathway—CCNE1—brain cancer	0.00113	0.0101	CbGpPWpGaD
Dextroamphetamine—CYP2D6—head—brain cancer	0.00113	0.00534	CbGeAlD
Dextroamphetamine—Constipation—Temozolomide—brain cancer	0.00113	0.00401	CcSEcCtD
Dextroamphetamine—Convulsion—Etoposide—brain cancer	0.00112	0.00398	CcSEcCtD
Dextroamphetamine—Hypertension—Etoposide—brain cancer	0.00111	0.00397	CcSEcCtD
Dextroamphetamine—Dizziness—Hydroxyurea—brain cancer	0.00111	0.00397	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Carmustine—brain cancer	0.00111	0.00396	CcSEcCtD
Dextroamphetamine—Chest pain—Etoposide—brain cancer	0.0011	0.00391	CcSEcCtD
Dextroamphetamine—Abdominal pain—Carmustine—brain cancer	0.00108	0.00383	CcSEcCtD
Dextroamphetamine—Body temperature increased—Carmustine—brain cancer	0.00108	0.00383	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Temozolomide—brain cancer	0.00108	0.00383	CcSEcCtD
Dextroamphetamine—Vomiting—Hydroxyurea—brain cancer	0.00107	0.00381	CcSEcCtD
Dextroamphetamine—Rash—Hydroxyurea—brain cancer	0.00106	0.00378	CcSEcCtD
Dextroamphetamine—Dermatitis—Hydroxyurea—brain cancer	0.00106	0.00378	CcSEcCtD
Dextroamphetamine—Headache—Hydroxyurea—brain cancer	0.00106	0.00376	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Etoposide—brain cancer	0.00105	0.00375	CcSEcCtD
Dextroamphetamine—Infection—Etoposide—brain cancer	0.00105	0.00372	CcSEcCtD
Dextroamphetamine—Urticaria—Temozolomide—brain cancer	0.00105	0.00372	CcSEcCtD
Dextroamphetamine—Body temperature increased—Temozolomide—brain cancer	0.00104	0.0037	CcSEcCtD
Dextroamphetamine—Abdominal pain—Temozolomide—brain cancer	0.00104	0.0037	CcSEcCtD
Dextroamphetamine—CYP2D6—central nervous system—brain cancer	0.00103	0.00487	CbGeAlD
Dextroamphetamine—Tachycardia—Etoposide—brain cancer	0.00103	0.00366	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Etoposide—brain cancer	0.00102	0.00362	CcSEcCtD
Dextroamphetamine—CYP2D6—cerebellum—brain cancer	0.00101	0.00476	CbGeAlD
Dextroamphetamine—Anorexia—Etoposide—brain cancer	0.001	0.00357	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Carmustine—brain cancer	0.001	0.00357	CcSEcCtD
Dextroamphetamine—Nausea—Hydroxyurea—brain cancer	0.001	0.00356	CcSEcCtD
Dextroamphetamine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.001	0.00889	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000987	0.00877	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Dopaminergic Neurogenesis—STAT3—brain cancer	0.000979	0.0087	CbGpPWpGaD
Dextroamphetamine—Asthenia—Carmustine—brain cancer	0.000977	0.00348	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Temozolomide—brain cancer	0.000969	0.00345	CcSEcCtD
Dextroamphetamine—Asthenia—Temozolomide—brain cancer	0.000944	0.00336	CcSEcCtD
Dextroamphetamine—Dyspnoea—Etoposide—brain cancer	0.000939	0.00334	CcSEcCtD
Dextroamphetamine—Somnolence—Etoposide—brain cancer	0.000936	0.00333	CcSEcCtD
Dextroamphetamine—Diarrhoea—Carmustine—brain cancer	0.000932	0.00332	CcSEcCtD
Dextroamphetamine—Decreased appetite—Etoposide—brain cancer	0.000915	0.00326	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Etoposide—brain cancer	0.000909	0.00324	CcSEcCtD
Dextroamphetamine—Fatigue—Etoposide—brain cancer	0.000908	0.00323	CcSEcCtD
Dextroamphetamine—Dizziness—Carmustine—brain cancer	0.0009	0.00321	CcSEcCtD
Dextroamphetamine—Constipation—Etoposide—brain cancer	0.0009	0.00321	CcSEcCtD
Dextroamphetamine—Diarrhoea—Temozolomide—brain cancer	0.0009	0.00321	CcSEcCtD
Dextroamphetamine—Dizziness—Temozolomide—brain cancer	0.00087	0.0031	CcSEcCtD
Dextroamphetamine—Vomiting—Carmustine—brain cancer	0.000866	0.00308	CcSEcCtD
Dextroamphetamine—TAAR1—GPCR ligand binding—SHH—brain cancer	0.000863	0.00767	CbGpPWpGaD
Dextroamphetamine—Gastrointestinal pain—Etoposide—brain cancer	0.000861	0.00307	CcSEcCtD
Dextroamphetamine—TAAR1—Signaling by GPCR—PTCH2—brain cancer	0.00086	0.00764	CbGpPWpGaD
Dextroamphetamine—Rash—Carmustine—brain cancer	0.000859	0.00306	CcSEcCtD
Dextroamphetamine—Dermatitis—Carmustine—brain cancer	0.000858	0.00305	CcSEcCtD
Dextroamphetamine—Headache—Carmustine—brain cancer	0.000853	0.00304	CcSEcCtD
Dextroamphetamine—Vomiting—Temozolomide—brain cancer	0.000837	0.00298	CcSEcCtD
Dextroamphetamine—Urticaria—Etoposide—brain cancer	0.000836	0.00298	CcSEcCtD
Dextroamphetamine—Abdominal pain—Etoposide—brain cancer	0.000832	0.00296	CcSEcCtD
Dextroamphetamine—Body temperature increased—Etoposide—brain cancer	0.000832	0.00296	CcSEcCtD
Dextroamphetamine—Rash—Temozolomide—brain cancer	0.00083	0.00295	CcSEcCtD
Dextroamphetamine—Dermatitis—Temozolomide—brain cancer	0.000829	0.00295	CcSEcCtD
Dextroamphetamine—Headache—Temozolomide—brain cancer	0.000824	0.00294	CcSEcCtD
Dextroamphetamine—TAAR1—GPCR ligand binding—SMO—brain cancer	0.000818	0.00727	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR ligand binding—PTCH1—brain cancer	0.000818	0.00727	CbGpPWpGaD
Dextroamphetamine—CYP2D6—brain—brain cancer	0.000817	0.00387	CbGeAlD
Dextroamphetamine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000811	0.0072	CbGpPWpGaD
Dextroamphetamine—Nausea—Carmustine—brain cancer	0.000809	0.00288	CcSEcCtD
Dextroamphetamine—TAAR1—Signaling Pathways—OR14C36—brain cancer	0.000788	0.007	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—OR4C12—brain cancer	0.000788	0.007	CbGpPWpGaD
Dextroamphetamine—Nausea—Temozolomide—brain cancer	0.000782	0.00278	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Etoposide—brain cancer	0.000776	0.00276	CcSEcCtD
Dextroamphetamine—Asthenia—Etoposide—brain cancer	0.000755	0.00269	CcSEcCtD
Dextroamphetamine—TAAR1—GPCR downstream signaling—ABR—brain cancer	0.000743	0.0066	CbGpPWpGaD
Dextroamphetamine—Diarrhoea—Etoposide—brain cancer	0.00072	0.00257	CcSEcCtD
Dextroamphetamine—Dizziness—Etoposide—brain cancer	0.000696	0.00248	CcSEcCtD
Dextroamphetamine—SLC18A2—Transmembrane transport of small molecules—S100A10—brain cancer	0.00068	0.00604	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—ABR—brain cancer	0.000675	0.00599	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—DTX2—brain cancer	0.00067	0.00595	CbGpPWpGaD
Dextroamphetamine—Vomiting—Etoposide—brain cancer	0.000669	0.00238	CcSEcCtD
Dextroamphetamine—Rash—Etoposide—brain cancer	0.000664	0.00236	CcSEcCtD
Dextroamphetamine—Dermatitis—Etoposide—brain cancer	0.000663	0.00236	CcSEcCtD
Dextroamphetamine—Headache—Etoposide—brain cancer	0.00066	0.00235	CcSEcCtD
Dextroamphetamine—ADRA1B—G alpha (12/13) signalling events—VAV1—brain cancer	0.00065	0.00577	CbGpPWpGaD
Dextroamphetamine—Nausea—Etoposide—brain cancer	0.000625	0.00223	CcSEcCtD
Dextroamphetamine—SLC6A3—Dopaminergic Neurogenesis—STAT3—brain cancer	0.000584	0.00519	CbGpPWpGaD
Dextroamphetamine—ADRA1A—G alpha (12/13) signalling events—VAV1—brain cancer	0.000577	0.00513	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—PTCH2—brain cancer	0.000508	0.00451	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—HES5—brain cancer	0.000492	0.00437	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—STRADA—brain cancer	0.000478	0.00424	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—TRPC6—brain cancer	0.00047	0.00418	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Transmembrane transport of small molecules—S100A10—brain cancer	0.000457	0.00406	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—SHH—brain cancer	0.000443	0.00393	CbGpPWpGaD
Dextroamphetamine—ADRA1B—AMPK Signaling—PIK3CG—brain cancer	0.000441	0.00392	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Biological oxidations—CYP2C9—brain cancer	0.000431	0.00383	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—TRPC6—brain cancer	0.000427	0.00379	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	0.000425	0.00377	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—PTCH2—brain cancer	0.000424	0.00377	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—PTCH1—brain cancer	0.00042	0.00373	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—SMO—brain cancer	0.00042	0.00373	CbGpPWpGaD
Dextroamphetamine—ADRA1B—G alpha (q) signalling events—TRPC6—brain cancer	0.000418	0.00371	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—S100A10—brain cancer	0.000405	0.0036	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—ABR—brain cancer	0.000399	0.00354	CbGpPWpGaD
Dextroamphetamine—ADRA1A—AMPK Signaling—PIK3CG—brain cancer	0.000392	0.00348	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—GLI2—brain cancer	0.000385	0.00342	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—PTCH2—brain cancer	0.000377	0.00334	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	0.000373	0.00332	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—OR4C12—brain cancer	0.000372	0.0033	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—OR14C36—brain cancer	0.000372	0.0033	CbGpPWpGaD
Dextroamphetamine—ADRA1A—G alpha (q) signalling events—TRPC6—brain cancer	0.000371	0.00329	CbGpPWpGaD
Dextroamphetamine—ADRA1B—LPA receptor mediated events—RELA—brain cancer	0.000366	0.00325	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—GLI1—brain cancer	0.000362	0.00322	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—VAV1—brain cancer	0.000352	0.00313	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—SUFU—brain cancer	0.000343	0.00305	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—OR4C12—brain cancer	0.000338	0.003	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—OR14C36—brain cancer	0.000338	0.003	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	0.000332	0.00295	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—GFAP—brain cancer	0.000331	0.00294	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—OR4C12—brain cancer	0.00033	0.00293	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—OR14C36—brain cancer	0.00033	0.00293	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—VAV1—brain cancer	0.00032	0.00284	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000314	0.00279	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—HEY1—brain cancer	0.000314	0.00279	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—DLL1—brain cancer	0.000308	0.00273	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—OR4C12—brain cancer	0.0003	0.00266	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—OR14C36—brain cancer	0.0003	0.00266	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—SHH—brain cancer	0.000262	0.00232	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—TRPC6—brain cancer	0.000252	0.00224	CbGpPWpGaD
Dextroamphetamine—ADRA1B—LPA receptor mediated events—EGFR—brain cancer	0.000252	0.00224	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—PTCH1—brain cancer	0.000248	0.0022	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—SMO—brain cancer	0.000248	0.0022	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—PIK3CG—brain cancer	0.000224	0.00199	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—SHH—brain cancer	0.000218	0.00194	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PTCH2—brain cancer	0.000218	0.00193	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000211	0.00188	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—PTCH1—brain cancer	0.000207	0.00184	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—SMO—brain cancer	0.000207	0.00184	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—PIK3CG—brain cancer	0.000203	0.00181	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—OR14C36—brain cancer	0.000199	0.00177	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—OR4C12—brain cancer	0.000199	0.00177	CbGpPWpGaD
Dextroamphetamine—ADRA1B—AMPK Signaling—TP53—brain cancer	0.000199	0.00177	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—NOTCH2—brain cancer	0.000198	0.00176	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—SHH—brain cancer	0.000194	0.00172	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PTCH2—brain cancer	0.000193	0.00172	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—VAV1—brain cancer	0.000189	0.00168	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—ABR—brain cancer	0.000188	0.00167	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000187	0.00166	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—PTCH1—brain cancer	0.000184	0.00163	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—SMO—brain cancer	0.000184	0.00163	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—OR14C36—brain cancer	0.000177	0.00157	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—OR4C12—brain cancer	0.000177	0.00157	CbGpPWpGaD
Dextroamphetamine—ADRA1A—AMPK Signaling—TP53—brain cancer	0.000177	0.00157	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—ABR—brain cancer	0.000171	0.00152	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—DTX2—brain cancer	0.00017	0.00151	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—ABR—brain cancer	0.000167	0.00148	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—HES1—brain cancer	0.000163	0.00144	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—IL2—brain cancer	0.000157	0.0014	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—PDGFRA—brain cancer	0.000155	0.00138	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—ABR—brain cancer	0.000152	0.00135	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—DTX2—brain cancer	0.000151	0.00134	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—SPP1—brain cancer	0.00015	0.00134	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—IL2—brain cancer	0.000143	0.00127	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—IRS2—brain cancer	0.000136	0.00121	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PTCH2—brain cancer	0.000129	0.00114	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HES5—brain cancer	0.000124	0.00111	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—STRADA—brain cancer	0.000121	0.00107	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—APC—brain cancer	0.00012	0.00107	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—PIK3CG—brain cancer	0.00012	0.00107	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—TRPC6—brain cancer	0.000119	0.00106	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PTCH2—brain cancer	0.000114	0.00101	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—SHH—brain cancer	0.000112	0.000995	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HES5—brain cancer	0.000111	0.000982	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—EGFR—brain cancer	0.000109	0.000972	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—TRPC6—brain cancer	0.000108	0.00096	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—STRADA—brain cancer	0.000107	0.000953	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—SMO—brain cancer	0.000106	0.000944	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PTCH1—brain cancer	0.000106	0.000944	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—TRPC6—brain cancer	0.000106	0.000939	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ABR—brain cancer	0.000101	0.000896	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—SHH—brain cancer	9.95e-05	0.000884	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—GLI2—brain cancer	9.74e-05	0.000865	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—TRPC6—brain cancer	9.6e-05	0.000853	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	9.56e-05	0.000849	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—SMO—brain cancer	9.44e-05	0.000838	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PTCH1—brain cancer	9.44e-05	0.000838	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—RELA—brain cancer	9.38e-05	0.000833	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—ERBB2—brain cancer	9.32e-05	0.000828	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—GLI1—brain cancer	9.16e-05	0.000813	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ABR—brain cancer	8.96e-05	0.000796	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—VAV1—brain cancer	8.92e-05	0.000792	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SUFU—brain cancer	8.68e-05	0.000771	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GLI2—brain cancer	8.65e-05	0.000768	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	8.49e-05	0.000754	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—IL2—brain cancer	8.45e-05	0.00075	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—GFAP—brain cancer	8.37e-05	0.000744	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CCND1—brain cancer	8.24e-05	0.000732	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CTNNB1—brain cancer	8.16e-05	0.000724	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GLI1—brain cancer	8.13e-05	0.000722	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—VAV1—brain cancer	8.1e-05	0.000719	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HEY1—brain cancer	7.94e-05	0.000705	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—VAV1—brain cancer	7.92e-05	0.000703	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—DLL1—brain cancer	7.79e-05	0.000692	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SUFU—brain cancer	7.71e-05	0.000685	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GFAP—brain cancer	7.44e-05	0.000661	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CYP2C9—brain cancer	7.37e-05	0.000654	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—VAV1—brain cancer	7.19e-05	0.000639	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—VEGFA—brain cancer	7.18e-05	0.000638	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—STAT3—brain cancer	7.11e-05	0.000631	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HEY1—brain cancer	7.05e-05	0.000626	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—DLL1—brain cancer	6.92e-05	0.000614	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SHH—brain cancer	6.62e-05	0.000588	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—MYC—brain cancer	6.61e-05	0.000587	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—EGFR—brain cancer	6.46e-05	0.000574	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TRPC6—brain cancer	6.38e-05	0.000567	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SMO—brain cancer	6.28e-05	0.000557	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PTCH1—brain cancer	6.28e-05	0.000557	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—BSG—brain cancer	6.26e-05	0.000556	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SHH—brain cancer	5.88e-05	0.000522	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TRPC6—brain cancer	5.67e-05	0.000504	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—PIK3CG—brain cancer	5.66e-05	0.000503	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PTCH1—brain cancer	5.57e-05	0.000495	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SMO—brain cancer	5.57e-05	0.000495	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—TP53—brain cancer	5.42e-05	0.000482	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—IDH1—brain cancer	5.39e-05	0.000478	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PIK3CG—brain cancer	5.14e-05	0.000457	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PIK3CG—brain cancer	5.03e-05	0.000447	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NOTCH2—brain cancer	5.02e-05	0.000446	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—VAV1—brain cancer	4.78e-05	0.000425	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PIK3CG—brain cancer	4.57e-05	0.000406	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NOTCH2—brain cancer	4.46e-05	0.000396	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ENO2—brain cancer	4.26e-05	0.000378	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—VAV1—brain cancer	4.25e-05	0.000377	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HES1—brain cancer	4.11e-05	0.000365	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—IL2—brain cancer	3.98e-05	0.000354	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PDGFRA—brain cancer	3.92e-05	0.000348	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SPP1—brain cancer	3.8e-05	0.000338	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HES1—brain cancer	3.65e-05	0.000325	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—IL2—brain cancer	3.62e-05	0.000321	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—IL2—brain cancer	3.54e-05	0.000314	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PDGFRA—brain cancer	3.48e-05	0.000309	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IRS2—brain cancer	3.44e-05	0.000305	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SPP1—brain cancer	3.38e-05	0.0003	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—IL2—brain cancer	3.21e-05	0.000285	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IRS2—brain cancer	3.05e-05	0.000271	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PIK3CG—brain cancer	3.04e-05	0.00027	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—APC—brain cancer	3.04e-05	0.00027	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—EGFR—brain cancer	2.77e-05	0.000246	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PIK3CG—brain cancer	2.7e-05	0.00024	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—APC—brain cancer	2.7e-05	0.00024	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—EGFR—brain cancer	2.46e-05	0.000218	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—RELA—brain cancer	2.37e-05	0.000211	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ERBB2—brain cancer	2.36e-05	0.000209	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IL2—brain cancer	2.14e-05	0.00019	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—RELA—brain cancer	2.11e-05	0.000187	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ERBB2—brain cancer	2.09e-05	0.000186	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CCND1—brain cancer	2.08e-05	0.000185	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CTNNB1—brain cancer	2.06e-05	0.000183	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PIK3CG—brain cancer	1.95e-05	0.000173	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IL2—brain cancer	1.9e-05	0.000169	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCND1—brain cancer	1.85e-05	0.000164	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CTNNB1—brain cancer	1.83e-05	0.000163	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—VEGFA—brain cancer	1.82e-05	0.000161	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—STAT3—brain cancer	1.8e-05	0.00016	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MYC—brain cancer	1.67e-05	0.000148	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—EGFR—brain cancer	1.63e-05	0.000145	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—VEGFA—brain cancer	1.61e-05	0.000143	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—STAT3—brain cancer	1.6e-05	0.000142	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MYC—brain cancer	1.48e-05	0.000132	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—EGFR—brain cancer	1.45e-05	0.000129	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TP53—brain cancer	1.37e-05	0.000122	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TP53—brain cancer	1.22e-05	0.000108	CbGpPWpGaD
